CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Cash flow Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 06:00:03 16/07/26 am AEST			5-day change	1st Jan Change
228.22 ^USD	-1.29%		-0.20%	+14.41%

14/07	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT
14/07	Baird Adjusts Charles River Laboratories International Price Target to $255 From $213, Maintains Outperform Rating	MT

8ea6f9edd81d2c6d4919964f5c3d.21Ji6qV86AXMatvzJ2a-2qM7sZZIN21Ujx-y1_jbDJc.iiVXicgQpn3hHJ-YSQDaiOhdwuUBfwYiyyvniMitP9SVFxCP6gavaasong

Published financial data: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.54B	3.98B	4.13B	4.05B	4.02B
Total Revenues	3.54B	3.98B	4.13B	4.05B	4.02B
Cost of Goods Sold, Total	2.2B	2.51B	2.6B	2.64B	2.61B
Gross Profit	1.34B	1.46B	1.53B	1.41B	1.4B
Selling General & Admin Expenses, Total	578M	658M	736M	724M	728M
Amortization of Goodwill and Intangible Assets - (IS)	125M	147M	137M	138M	179M
Other Operating Expenses, Total	703M	804M	873M	862M	907M
Operating Income	634M	659M	656M	546M	498M
Interest Expense, Total	-73.91M	-59.29M	-137M	-126M	-107M
Interest And Investment Income	652K	780K	5.2M	8.58M	4.94M
Net Interest Expenses	-73.26M	-58.51M	-132M	-118M	-102M
Income (Loss) On Equity Invest.	-30.42M	-26.78M	97.83M	-12.91M	-24.91M
Currency Exchange Gains (Loss)	-31.8M	-46.53M	-	-	-
Other Non Operating Income (Expenses)	5.06M	-18.4M	-96.68M	2.02M	3.35M
EBT, Excl. Unusual Items	504M	508M	526M	417M	374M
Restructuring Charges	-6.86M	-	-29.68M	-107M	-99.81M
Merger & Related Restructuring Charges	-39.1M	-8.74M	-12.38M	-1.5M	-1.2M
Impairment of Goodwill	-	-	-	-215M	-165M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	22.7M	123M	-961K	-659K	3.38M
Asset Writedown	-	-	-	-	-211M
Other Unusual Items	-	-	98.5M	-	-
EBT, Incl. Unusual Items	481M	623M	581M	93.11M	-99.5M
Income Tax Expense	81.87M	130M	101M	67.82M	42.66M
Earnings From Continuing Operations	399M	493M	480M	25.29M	-142M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	399M	493M	480M	25.29M	-142M
Minority Interest	-7.86M	-6.38M	-5.75M	-3.09M	-2.18M
Net Income - (IS)	391M	486M	475M	22.2M	-144M
Preferred Dividend and Other Adjustments	-	-	-	11.91M	-
Net Income to Common Incl Extra Items	391M	486M	475M	10.3M	-144M
Net Income to Common Excl. Extra Items	391M	486M	475M	10.3M	-144M
Per Share Items
Net EPS - Basic	7.77	9.57	9.27	0.2	-2.91
Basic EPS - Continuing Operations	7.77	9.57	9.27	0.2	-2.91
Basic Weighted Average Shares Outstanding	50.29M	50.81M	51.23M	51.38M	49.56M
Net EPS - Diluted	7.6	9.48	9.22	0.2	-2.91
Diluted EPS - Continuing Operations	7.6	9.48	9.22	0.2	-2.91
Diluted Weighted Average Shares Outstanding	51.42M	51.3M	51.45M	51.63M	49.56M
Normalized Basic EPS	6.11	6.13	6.3	5.02	4.67
Normalized Diluted EPS	5.97	6.07	6.28	4.99	4.67
Supplemental Items
EBITDA	900M	962M	970M	870M	877M
EBITA	759M	805M	794M	675M	677M
EBIT	634M	659M	656M	546M	498M
EBITDAR	951M	1.04B	1.06B	972M	986M
Total Revenues (As Reported)	3.54B	3.98B	4.13B	4.05B	4.02B
Effective Tax Rate - (Ratio)	17.03	20.93	17.36	72.84	-42.87
Current Domestic Taxes	41.98M	94.84M	66.91M	48.52M	20.6M
Current Foreign Taxes	60.2M	68.64M	85.36M	86.49M	97.43M
Total Current Taxes	102M	163M	152M	135M	118M
Deferred Domestic Taxes	-34.2M	-31.97M	-52.13M	-60.27M	-52.95M
Deferred Foreign Taxes	13.89M	-1.13M	779K	-6.92M	-22.42M
Total Deferred Taxes	-20.31M	-33.11M	-51.35M	-67.19M	-75.37M
Normalized Net Income	307M	311M	323M	258M	232M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	1.28M	1.44M	1.48M	1.55M	1.39M
Non-Cash Pension Expense	-889K	2.16M	3.15M	4.98M	4.39M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Net Rental Expense, Total	50.78M	74.68M	89.05M	102M	109M
Imputed Operating Lease Interest Expense	11.75M	11.61M	31.04M	34.88M	34.63M
Imputed Operating Lease Depreciation	39.04M	63.06M	58.02M	67.11M	74.82M
Stock-Based Comp., COGS (Total)	13.09M	14.85M	15.05M	15.66M	16.72M
Stock-Based Comp., SG&A Exp. (Total)	58.39M	58.76M	57M	54.23M	54.37M
Total Stock-Based Compensation	71.47M	73.62M	72.05M	69.89M	71.08M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	241M	234M	277M	195M	214M
Short Term Investments	1.06M	-	-	-	-
Total Cash And Short Term Investments	242M	234M	277M	195M	214M
Accounts Receivable, Total	643M	752M	780M	721M	709M
Total Receivables	643M	752M	780M	721M	709M
Inventory	199M	256M	380M	279M	299M
Prepaid Expenses	93.54M	89.34M	87.88M	103M	96.11M
Restricted Cash	4.02M	6.19M	5.8M	9.54M	666K
Other Current Assets, Total	92.22M	101M	77.58M	96.26M	129M
Total Current Assets	1.27B	1.44B	1.61B	1.4B	1.45B
Gross Property Plant And Equipment	2.69B	3.02B	3.37B	3.47B	3.55B
Accumulated Depreciation	-1.1B	-1.16B	-1.34B	-1.45B	-1.54B
Net Property Plant And Equipment	1.58B	1.86B	2.03B	2.02B	2.02B
Long-term Investments	201M	312M	244M	218M	207M
Goodwill	2.71B	2.85B	3.1B	2.85B	2.76B
Other Intangibles, Total	1.06B	955M	864M	723M	340M
Deferred Tax Assets Long-Term	40.23M	41.26M	40.28M	42.18M	67.33M
Other Long-Term Assets, Total	152M	148M	309M	278M	293M
Total Assets	7.02B	7.6B	8.2B	7.53B	7.14B
Liabilities
Accounts Payable, Total	198M	206M	169M	140M	149M
Accrued Expenses, Total	475M	417M	441M	386M	509M
Current Portion of Long-Term Debt	101K	1.35M	3.17M	155K	166K
Current Portion of Leases	35.96M	48.86M	57.31M	56.93M	60.89M
Current Income Taxes Payable	26.16M	39.9M	38.8M	31.9M	39M
Unearned Revenue Current, Total	279M	356M	327M	338M	317M
Other Current Liabilities	18.7M	22.83M	18.38M	40.58M	45.5M
Total Current Liabilities	1.03B	1.09B	1.06B	994M	1.12B
Long-Term Debt	2.64B	2.68B	2.62B	2.21B	2.11B
Long-Term Leases	278M	418M	445M	509M	459M
Unearned Revenue Non Current	20.58M	25.8M	30.92M	34.29M	45.63M
Pension & Other Post Retirement Benefits	105M	-	-	-	-
Deferred Tax Liability Non Current	240M	216M	191M	107M	95.2M
Other Non Current Liabilities	117M	149M	192M	161M	92.67M
Total Liabilities	4.43B	4.58B	4.54B	4.02B	3.92B
Common Stock, Total	505K	509K	513K	511K	492K
Additional Paid In Capital	1.72B	1.8B	1.91B	1.97B	1.95B
Retained Earnings	981M	1.43B	1.89B	1.81B	1.39B
Treasury Stock	-	-	-	-	-
Comprehensive Income and Other	-165M	-262M	-196M	-317M	-172M
Total Common Equity	2.53B	2.98B	3.6B	3.46B	3.16B
Minority Interest	57.17M	47.21M	62.12M	46.58M	46.56M
Total Equity	2.59B	3.02B	3.66B	3.51B	3.21B
Total Liabilities And Equity	7.02B	7.6B	8.2B	7.53B	7.14B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	50.49M	50.99M	51.35M	51.14M	49.23M
ECS Total Common Shares Outstanding	50.48M	50.94M	51.34M	51.14M	49.22M
Book Value / Share	50.21	58.42	70.06	67.69	64.3
Tangible Book Value	-1.24B	-829M	-362M	-109M	60.38M
Tangible Book Value Per Share	-24.53	-16.27	-7.06	-2.12	1.23
Total Debt	2.95B	3.15B	3.13B	2.78B	2.63B
Net Debt	2.71B	2.91B	2.85B	2.59B	2.42B
Debt Equivalent of Unfunded Proj. Benefit Obligation	36.97M	13.01M	21.22M	33.31M	32.17M
Debt Equivalent Oper. Leases	406M	597M	712M	816M	876M
Minority Interest, Total (Incl. Fin. Div)	57.17M	47.21M	62.12M	46.58M	46.56M
Equity Method Investments, Total	150M	312M	244M	218M	207M
Account Code - Inventory Valuation	6	6	6	6	5
Inventories - Raw Materials, Total	33.12M	38.89M	42.3M	43.04M	40.96M
Inventories - Work In Process, Total	40.27M	48.37M	59.73M	51.78M	88.74M
Inventories - Finished Goods, Total	126M	169M	278M	184M	169M
Land - (BS)	59.49M	58.19M	79.55M	71.74M	72.02M
Buildings, Total	988M	964M	1.05B	1.07B	1.1B
Machinery, Total	1B	1.11B	1.28B	1.33B	1.41B
Full Time Employees	18.6K	20K	20.4K	18.7K	18.3K
Part Time Employees	1.4K	1.4K	1.4K	1.4K	1.4K
Accumulated Allowance for Doubtful Accounts (Supple)	7.18M	11.28M	25.72M	18.3M	10.46M
Order Backlog	2.8B	3.5B	3.13B	2.79B	2.66B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	391M	486M	475M	22.2M	-144M
Depreciation & Amortization - CF	141M	157M	177M	196M	200M
Amortization of Goodwill and Intangible Assets - (CF)	125M	147M	137M	129M	179M
Depreciation & Amortization, Total	266M	304M	314M	325M	379M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-25.03M	-123M	961K	659K	-3.38M
Asset Writedown & Restructuring Costs	-	-	41.91M	276M	424M
(Income) Loss On Equity Investments - (CF)	30.42M	26.78M	-97.83M	12.91M	24.91M
Stock-Based Compensation (CF)	71.47M	73.62M	72.05M	69.89M	71.08M
Provision and Write-off of Bad Debts	-	6.71M	18.22M	14.77M	6.06M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-15.53M	-1.6M	-37.79M	43.6M	-33.67M
Change In Accounts Receivable	-26.63M	-151M	-33.43M	21.61M	35.74M
Change In Inventories	-25.16M	-78.52M	-62.3M	16.8M	-48.78M
Change In Accounts Payable	44.9M	-2.65M	-20.43M	-14.27M	2.87M
Change in Unearned Revenues	3.52M	88.12M	-37.31M	25.12M	-23.49M
Change In Income Taxes	-	-	-	-	-
Change in Other Net Operating Assets	46.31M	-8.92M	51.09M	-79.6M	47.74M
Cash from Operations	761M	620M	684M	735M	738M
Capital Expenditure	-229M	-325M	-319M	-233M	-219M
Cash Acquisitions	-1.29B	-283M	-195M	-5.48M	-
Divestitures	123M	163M	-	-	17.44M
Investment in Marketable and Equity Securities, Total	-39.02M	-154M	-47.55M	-11.19M	-10.97M
Other Investing Activities, Total	264K	-9.35M	-2.29M	4.55M	3.36M
Cash from Investing	-1.44B	-608M	-563M	-245M	-209M
Long-Term Debt Issued, Total	6.95B	2.95B	776M	1.08B	1.23B
Total Debt Issued	6.95B	2.95B	776M	1.08B	1.23B
Long-Term Debt Repaid, Total	-6.24B	-2.93B	-852M	-1.49B	-1.35B
Total Debt Repaid	-6.24B	-2.93B	-852M	-1.49B	-1.35B
Issuance of Common Stock	45.65M	25.11M	25.6M	23.88M	714K
Repurchase of Common Stock	-40.71M	-38.65M	-24.16M	-119M	-361M
Other Financing Activities, Total	-40.58M	-48.65M	-11.64M	-43.44M	-54.98M
Cash from Financing	673M	-42.4M	-85.52M	-551M	-537M
Foreign Exchange Rate Adjustments	17.73M	25.58M	8.04M	-17.47M	18.83M
Net Change in Cash	13.2M	-5.1M	43.27M	-78.91M	10.43M
Supplemental Items
Cash Interest Paid	70.78M	101M	132M	123M	102M
Cash Income Tax Paid (Refund)	75.44M	75.91M	90.37M	126M	120M
Levered Free Cash Flow	631M	299M	219M	490M	572M
Unlevered Free Cash Flow	677M	336M	304M	569M	639M
Change In Net Working Capital	-172M	128M	174M	-65.84M	-97.43M
Net Debt Issued / Repaid	708M	19.79M	-75.32M	-412M	-122M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.34	5.63	5.19	4.34	4.24
Return on Total Capital	8.05	7.03	6.33	5.22	5.13
Return On Equity %	16.84	17.54	14.38	0.71	-4.23
Return on Common Equity	16.82	17.65	14.44	0.29	-4.36
Margin Analysis
Gross Profit Margin %	37.78	36.79	37.03	34.76	34.98
SG&A Margin	16.33	16.54	17.81	17.87	18.13
EBITDA Margin %	25.42	24.2	23.5	21.49	21.83
EBITA Margin %	21.45	20.25	19.22	16.66	16.86
EBIT Margin %	17.92	16.56	15.89	13.48	12.4
Income From Continuing Operations Margin %	11.27	12.39	11.63	0.62	-3.54
Net Income Margin %	11.04	12.23	11.49	0.55	-3.59
Net Avail. For Common Margin %	11.04	12.23	11.49	0.25	-3.59
Normalized Net Income Margin	8.68	7.83	7.82	6.36	5.77
Levered Free Cash Flow Margin	17.81	7.53	5.3	12.09	14.25
Unlevered Free Cash Flow Margin	19.12	8.46	7.37	14.04	15.92
Asset Turnover
Asset Turnover	0.57	0.54	0.52	0.52	0.55
Fixed Assets Turnover	2.45	2.31	2.12	2	1.99
Receivables Turnover (Average Receivables)	5.62	5.7	5.39	5.4	5.62
Inventory Turnover (Average Inventory)	11.45	11.05	8.18	8.02	9.04
Short Term Liquidity
Current Ratio	1.23	1.32	1.52	1.41	1.29
Quick Ratio	0.86	0.9	1	0.92	0.82
Operating Cash Flow to Current Liabilities	0.74	0.57	0.65	0.74	0.66
Days Sales Outstanding (Average Receivables)	64.81	65.09	67.56	67.47	64.81
Days Outstanding Inventory (Average Inventory)	31.8	33.58	44.52	45.38	40.27
Average Days Payable Outstanding	26.33	29.16	25.04	22.16	20
Cash Conversion Cycle (Average Days)	70.28	69.51	87.04	90.69	85.08
Long Term Solvency
Total Debt/Equity	113.91	104.1	85.46	79.28	81.95
Total Debt / Total Capital	53.25	51	46.08	44.22	45.04
LT Debt/Equity	112.52	102.44	83.8	77.65	80.05
Long-Term Debt / Total Capital	52.6	50.19	45.19	43.31	43.99
Total Liabilities / Total Assets	63.1	60.23	55.35	53.4	55
EBIT / Interest Expense	8.58	11.11	4.8	4.32	4.65
EBITDA / Interest Expense	12.86	17.49	7.75	7.7	9.21
(EBITDA - Capex) / Interest Expense	9.77	12.01	5.42	5.86	7.17
Total Debt / EBITDA	3.11	3.03	2.95	2.86	2.67
Net Debt / EBITDA	2.85	2.81	2.69	2.66	2.45
Total Debt / (EBITDA - Capex)	4.09	4.42	4.22	3.76	3.43
Net Debt / (EBITDA - Capex)	3.75	4.09	3.85	3.5	3.15
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	21.08	12.31	3.86	-1.92	-0.85
Gross Profit, 1 Yr. Growth %	23.96	9.59	4.19	-7.93	-0.23
EBITDA, 1 Yr. Growth %	30.3	7.76	-0.01	-9.88	0.7
EBITA, 1 Yr. Growth %	33.76	7.01	-2.39	-14.48	0.28
EBIT, 1 Yr. Growth %	39.19	4.94	-1.55	-16.25	-8.81
Earnings From Cont. Operations, 1 Yr. Growth %	9.18	23.51	-2.48	-94.74	-662.11
Net Income, 1 Yr. Growth %	7.32	24.36	-2.39	-95.32	-750.08
Normalized Net Income, 1 Yr. Growth %	1.84	2.8	2.09	-19.51	-10.11
Diluted EPS Before Extra, 1 Yr. Growth %	5.56	24.74	-2.74	-97.83	-1.56K
Accounts Receivable, 1 Yr. Growth %	4.07	17.03	3.72	-7.62	-1.67
Inventory, 1 Yr. Growth %	7.24	28.45	48.65	-26.75	7.38
Net Property, Plant and Equip., 1 Yr. Growth %	21.61	17.26	9.49	-0.85	0.01
Total Assets, 1 Yr. Growth %	27.93	8.24	7.79	-8.14	-5.22
Tangible Book Value, 1 Yr. Growth %	156.81	-33.06	-56.3	-70.04	-155.65
Common Equity, 1 Yr. Growth %	19.87	17.42	20.85	-3.76	-8.58
Cash From Operations, 1 Yr. Growth %	39.19	-18.55	10.37	7.41	0.42
Capital Expenditures, 1 Yr. Growth %	37.35	41.95	-1.91	-26.86	-5.93
Levered Free Cash Flow, 1 Yr. Growth %	125.4	-52.14	-28.1	126.66	16.9
Unlevered Free Cash Flow, 1 Yr. Growth %	102.76	-49.91	-10.88	88.6	12.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.21	16.61	8	0.93	-1.39
Gross Profit, 2 Yr. CAGR %	17.73	16.72	6.93	-2.06	-4.16
EBITDA, 2 Yr. CAGR %	23.93	19.49	3.84	-5.24	-4.59
EBITA, 2 Yr. CAGR %	26.12	20.88	2.24	-8.84	-7.22
EBIT, 2 Yr. CAGR %	27.9	22.47	1.7	-9.43	-12.42
Earnings From Cont. Operations, 2 Yr. CAGR %	25.29	16.12	9.75	-77.34	-45.6
Net Income, 2 Yr. CAGR %	24.56	15.53	10.18	-78.63	-44.85
Normalized Net Income, 2 Yr. CAGR %	20.46	3.41	2.25	-9.65	-21.91
Diluted EPS Before Extra, 2 Yr. CAGR %	22.43	14.75	10.14	-85.48	-43.8
Accounts Receivable, 2 Yr. CAGR %	11.83	10.36	10.18	-2.11	-4.69
Inventory, 2 Yr. CAGR %	11.34	17.37	38.18	4.35	-11.31
Net Property, Plant and Equip., 2 Yr. CAGR %	15.65	19.41	13.31	4.19	-0.42
Total Assets, 2 Yr. CAGR %	22.34	17.67	8.01	-0.49	-6.69
Tangible Book Value, 2 Yr. CAGR %	44.21	31.11	-45.91	-63.82	-59.17
Common Equity, 2 Yr. CAGR %	24.53	18.64	19.12	7.84	-6.2
Cash From Operations, 2 Yr. CAGR %	25.77	6.47	-5.19	8.88	3.86
Capital Expenditures, 2 Yr. CAGR %	27.6	39.63	18	-15.3	-17.05
Levered Free Cash Flow, 2 Yr. CAGR %	31.85	5.41	-41.05	26.98	63.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.95	1.98	-32.91	29.18	46.06
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.03	14.9	12.2	4.59	0.33
Gross Profit, 3 Yr. CAGR %	16.65	14.87	12.52	1.73	-1.45
EBITDA, 3 Yr. CAGR %	21.32	17.99	12.91	-1.1	-3.3
EBITA, 3 Yr. CAGR %	23.1	19.04	12.94	-3.85	-5.89
EBIT, 3 Yr. CAGR %	22.84	19.3	14.33	-4.89	-9.23
Earnings From Cont. Operations, 3 Yr. CAGR %	20.63	24.7	9.56	-60.12	-33.92
Net Income, 3 Yr. CAGR %	19.98	24.49	9.22	-61.56	-33.29
Normalized Net Income, 3 Yr. CAGR %	19.57	13.72	3.51	-5.85	-9.8
Diluted EPS Before Extra, 3 Yr. CAGR %	18.3	23.2	8.59	-70.26	-32.53
Accounts Receivable, 3 Yr. CAGR %	10.83	13.54	8.1	3.89	-1.97
Inventory, 3 Yr. CAGR %	15.91	16.77	26.99	11.83	5.35
Net Property, Plant and Equip., 3 Yr. CAGR %	19.3	16.19	16.01	8.38	2.78
Total Assets, 3 Yr. CAGR %	22.13	17.45	14.28	2.34	-2.09
Tangible Book Value, 3 Yr. CAGR %	31.81	11.66	-9.09	-55.58	-58.24
Common Equity, 3 Yr. CAGR %	24.38	22.11	19.37	10.94	2.07
Cash From Operations, 3 Yr. CAGR %	20.26	8.81	7.76	-1.16	5.98
Capital Expenditures, 3 Yr. CAGR %	17.77	32.21	24.12	0.61	-12.29
Levered Free Cash Flow, 3 Yr. CAGR %	32.64	-6.21	-6.7	-8.04	23.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	29.72	-5.68	-2.02	-5.6	23.34
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.06	16.44	12.75	9.09	6.55
Gross Profit, 5 Yr. CAGR %	15.24	15.17	12.66	7.85	5.52
EBITDA, 5 Yr. CAGR %	17.62	16.72	14	8.24	5.4
EBITA, 5 Yr. CAGR %	19.25	17.83	14.29	7.17	4.2
EBIT, 5 Yr. CAGR %	18.36	16.04	13.91	7.08	2.54
Earnings From Cont. Operations, 5 Yr. CAGR %	20.64	31.44	16.15	-36.96	-17.2
Net Income, 5 Yr. CAGR %	20.36	31.56	15.96	-38.48	-16.9
Normalized Net Income, 5 Yr. CAGR %	13.93	10.05	12.44	4.01	-4.47
Diluted EPS Before Extra, 5 Yr. CAGR %	18.74	30.14	14.97	-47.62	-16.56
Accounts Receivable, 5 Yr. CAGR %	12.05	11.84	10.57	7	2.79
Inventory, 5 Yr. CAGR %	15.75	17.35	24.35	11.63	10
Net Property, Plant and Equip., 5 Yr. CAGR %	15.95	18.89	16.87	11.23	9.14
Total Assets, 5 Yr. CAGR %	20.97	21.01	16.27	9.91	5.38
Tangible Book Value, 5 Yr. CAGR %	29.11	44.94	-7.7	-28.86	-34
Common Equity, 5 Yr. CAGR %	24.82	23.28	22.25	16.19	8.4
Cash From Operations, 5 Yr. CAGR %	19.3	14.4	9.35	8.84	6.18
Capital Expenditures, 5 Yr. CAGR %	32.85	31.55	17.86	10.64	5.64
Levered Free Cash Flow, 5 Yr. CAGR %	19.27	8.28	-4.14	6.18	16.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.43	8.89	-0.38	7.24	14.6